Profile data is unavailable for this security.
About the company
Eurofins-Cerep SA, formerly Cerep SA is a France-based company that specializes in the pre-clinical research, discovery and development of new pharmaceutical drugs. The Company, using its BioPrint technology systems that analyzes pharmaceutical drugs on the market, those that have been withdrawn, and those that failed in the development stages, builds up predictive models of the potential of new drugs. These predictions are based on the drugs' chemical structure and their performance in vitro. The Company then offers solutions to the pharmaceutical and biotechnology sectors on reducing time and costs in the early stages of the drug development process. Clients can also gain access to some of the Company's technology by subscribing to BioPrint. The Company’s maximum revenue is generated through Exports accounts.
- Revenue in EUR (TTM)46.17m
- Net income in EUR9.21m
- Incorporated1990
- Employees233.00
- LocationEurofins-Cerep SALe bois l'EvequeCELLE-LEVESCAULT 86600FranceFRA
- Phone+33 549893000
- Fax+33 549432170
- Websitehttps://www.eurofins.fr/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valbiotis SA | 4.39m | -9.14m | 64.92m | 48.00 | -- | 4.37 | -- | 14.78 | -0.8427 | -0.8427 | 0.3832 | 0.9411 | 0.1816 | 0.7079 | 1.76 | 91,479.16 | -37.81 | -36.56 | -55.22 | -50.24 | 88.93 | 49.62 | -208.22 | -812.27 | 2.79 | -39.11 | 0.3656 | -- | 163.42 | 204.47 | -41.83 | -- | -14.52 | -- |
| AFYREN SA | 3.38m | -9.59m | 70.78m | 122.00 | -- | 1.15 | -- | 20.95 | -0.3696 | -0.3696 | 0.1303 | 2.37 | 0.0435 | -- | 5.39 | 27,696.72 | -12.35 | -9.58 | -13.42 | -10.46 | 92.63 | 95.57 | -283.69 | -162.61 | -- | -1.62 | 0.0719 | -- | -2.23 | -- | -4.20 | -- | -- | -- |
| AB Science SA | 777.00k | -16.89m | 99.87m | 89.00 | -- | -- | -- | 128.54 | -0.3561 | -0.3561 | 0.0164 | -0.3879 | 0.0284 | 0.394 | 2.50 | 7,471.15 | -61.64 | -70.81 | -237.22 | -316.63 | 88.16 | 91.37 | -2,173.10 | -1,225.49 | 1.41 | -- | 135.44 | -- | -40.39 | -11.24 | 5.86 | -- | 5.07 | -- |
| Maat Pharma SA | 2.23m | -19.72m | 108.03m | 50.00 | -- | 5.28 | -- | 48.49 | -1.73 | -1.73 | 0.196 | 1.76 | 0.0508 | 4.84 | 4.16 | 44,560.00 | -44.99 | -35.49 | -58.93 | -42.98 | 74.28 | -- | -884.96 | -1,157.54 | 2.76 | -49.61 | 0.4075 | -- | 55.80 | -- | -43.78 | -- | 30.30 | -- |
| Eurofins-Cerep SA | 46.17m | 9.21m | 109.96m | 233.00 | 11.94 | 1.83 | 9.82 | 2.38 | 1,826.41 | 1,826.41 | 9,160.00 | 11,939.29 | 0.6814 | 1.66 | 6.04 | 220,892.00 | 13.60 | 15.19 | 16.06 | 18.94 | 85.57 | 67.30 | 19.95 | 19.72 | 5.17 | 112.42 | 0.00005 | 0.00 | 14.45 | 14.30 | 17.09 | 24.52 | -- | -- |
| DBV Technologies SA | 4.90m | -94.65m | 120.08m | 88.00 | -- | 0.78 | -- | 24.48 | -1.00 | -1.00 | 0.052 | 1.60 | 0.0209 | -- | 0.3738 | 71,076.30 | -40.35 | -64.67 | -46.22 | -80.94 | -- | 91.59 | -1,929.97 | -1,345.10 | -- | -- | 0.0128 | -- | -15.14 | -18.45 | 2.08 | -- | -38.41 | -- |
| Adocia SA | 5.73m | -20.55m | 120.37m | 100.00 | -- | -- | -- | 21.03 | -2.36 | -2.36 | 0.6532 | -1.90 | 0.1823 | -- | 16.79 | 55,048.08 | -65.43 | -25.65 | -341.43 | -37.22 | -- | -- | -358.85 | -101.11 | 0.5924 | -2.78 | 2.81 | -- | 692.73 | -10.08 | 69.67 | -- | -40.08 | -- |
| Ose Immunotherapeutics SA | 2.23m | -23.00m | 122.77m | 62.00 | -- | 5.30 | -- | 55.13 | -1.18 | -1.18 | 0.1166 | 1.06 | 0.0256 | -- | 3.22 | -- | -26.46 | -17.17 | -33.15 | -20.55 | -- | -- | -1,032.87 | -94.71 | -- | -97.81 | 0.6659 | -- | -87.83 | -38.07 | -29.52 | -- | -17.11 | -- |
| Transgene SA | 7.63m | -22.33m | 125.06m | 158.00 | -- | 7.99 | -- | 16.38 | -0.2227 | -0.2227 | 0.0759 | 0.1553 | 0.1368 | -- | 4.28 | 48,316.46 | -40.00 | -24.81 | -50.27 | -29.79 | -- | -- | -292.48 | -193.24 | -- | -- | 0.4764 | -- | -23.68 | 1.51 | 31.94 | -- | 14.44 | -- |
| Eurobio Scientific SA | 130.00m | 4.84m | 148.33m | 137.00 | 33.38 | 0.8987 | 6.37 | 1.14 | 0.4315 | 0.4315 | 11.59 | 16.02 | 0.4018 | 3.19 | 4.31 | 948,927.00 | 1.49 | 16.91 | 1.80 | 21.53 | 47.11 | 50.95 | 3.72 | 23.34 | 2.32 | 2.81 | 0.3666 | 0.00 | -14.81 | 20.80 | -80.61 | -- | 20.02 | -- |
| Inventiva SA | 17.48m | -110.43m | 155.33m | 112.00 | -- | -- | -- | 8.89 | -2.45 | -2.45 | 0.3854 | -0.6146 | 0.1884 | -- | 9.18 | 156,044.60 | -116.84 | -54.30 | -207.08 | -69.98 | -- | -- | -620.31 | -669.97 | 0.9524 | -19.98 | 6.96 | -- | 43.50 | 40.46 | -103.46 | -- | -0.33 | -- |
| Genfit SA | 38.18m | -28.89m | 159.62m | 159.00 | -- | 2.35 | -- | 4.18 | -0.5814 | -0.5814 | 0.7681 | 1.36 | 0.1961 | 542.00 | 3.52 | 240,100.60 | -14.84 | -12.57 | -18.55 | -15.30 | 94.32 | 94.96 | -75.69 | -76.23 | 2.94 | -7.78 | 0.5080 | -- | 43.70 | 38.49 | -21.82 | -- | -3.27 | -- |
Data as of Apr 15 2024. Currency figures normalised to Eurofins-Cerep SA's reporting currency: Euro EUR
